David N. Feldman, Member

Address:

Hiller, PC
641 Lexington Ave.
New York, NY 10022
Phone: (212) 319-4000, Ext. 4318
Email: DFeldman@hillerpc.com

David N. Feldman concentrates his practice on corporate and securities law and mergers and acquisitions, as well as general representation of public and private companies, entrepreneurs, investors, and private equity and venture capital firms. Mr. Feldman also advises emerging growth companies with regard to alternatives to traditional financing through initial public offerings. He is also considered an authority on public offerings through SEC Regulation A+. He published a book on that subject, called Regulation A+ and Other Alternatives to a Traditional IPO (John Wiley & Sons), in 2018.

Mr. Feldman also represents investors, social media sites, public and private issuers and applicants for grow and dispensary licenses in the emerging cannabis sector. In April 2019 the global guide Chambers & Partners ranked Mr. Feldman as a leading US attorney in cannabis law and one of only seven US lawyers in “band 1” for corporate and transactional work in the industry. In addition, in October 2018 the National Law Journal named him a “Cannabis Law Trailblazer” and in January 2019 Business Insider named him as a top lawyer in the cannabis industry.

David has also published The Entrepreneur’s Growth Startup Handbook: 7 Secrets to Venture Funding and Growth Success (2013) and the award-winning Reverse Mergers and Other Alternatives to a Traditional IPO (First Edition 2006, Second Edition 2009). David also pens the “Blunt Legal Talk” column on cannabis law for Honeysuckle magazine and is a contributor to Entrepreneur.com on cannabis issues. Additionally, he frequently speaks on cannabis as well as corporate matters and issues that small and mid-sized companies face, and is active on social media.

David also is a partner in Skip Intro Advisors, LLC, a cannabis consulting firm focused on strategic advisory, financial consulting, branding and technology. His blog (www.DavidFeldmanBlog.com) on entrepreneurship, cannabis and the regulatory environment, has been recognized by LexisNexis as a Top 25 corporate law blog, and his videos appear on my YouTube channel, The Entrepreneur’s Advocate.

Mr. Feldman is a graduate of the University of Pennsylvania Law School, and of the Wharton School of the University of Pennsylvania. He has served as chair of the board of Wharton’s global alumni association.

Cannabis

Mr. Feldman represents a wide range of clients, including entrepreneurial companies, investors, lenders, investment banking firms and other businesses, in the emerging legal cannabis industry. He provides guidance on private placements, public offerings, loan structuring and fund formation for cannabis companies, as well as corporate structuring advice and applications for grow, processing and dispensary licenses. He also advises on risk assessment issues for large, multinational businesses seeking to enter the cannabis industry.

Mr. Feldman is the former team lead of an AmLaw 100 firm’s Cannabis Industry Group. He frequently speaks at industry conferences and is quoted by numerous publications about legal developments and business news in this rapidly expanding market.

Representative Matters

Represented The Lovesac Company (Nasdaq:LOVE) in completing a $103,500,000 underwritten public offering of 2,875,000 shares of its common stock, which include 750,000 shares offered by the Company, 1,750,000 shares offered by certain selling stockholders of the Company and the exercise of the full over-allotment of 375,000 shares, at a price of $36.00 per share.
Represented an Army vet pro bono who is an advocate for access to cannabis for veterans for PTSD and other issues in setting up a not-for-profit to promote her activities as well as in acquiring a farm in upstate NY that will grow hemp under the NYS program and build “mini-homes” for vets in transition to do yoga, equine therapy and education about treatment options including cannabis.
Advising a large national accounting and consulting firm regarding assessing its risks in accepting cannabis industry clients.
Advising a Massachusetts licensed cannabis grower with regard to fundraising opportunities.
Advising a shareholder of a fast growing hemp company with regard to options for selling a portion of his shares.
Advising a U.S. registered broker-dealer with regard to assessing the risk of accepting cannabis industry clients.
Advising a nationally-distributed print and digital magazine focused on lifestyles related to cannabis on corporate governance matters.
Representing a company that tests DNA for purposes of matching cannabis strains, in connection with its seed financing round, preparing subscription and offering materials.
Representing a US-based, global venture capital fund manager that invests in a range of early-stage to growth companies supporting the fast-growing legal cannabis industry with creating a new fund.
Represented The Lovesac Company (NASDAQ: LOVE), a technology-driven modular furniture designer and manufacturer, in its $64.4 million initial public offering.
Represented The Lovesac Company (NASDAQ: LOVE) in completing a $43.7 million underwritten public sale of 2.3 million shares of Common Stock at $19.00 per share.
Assisted The Lovesac Company, a furniture retailer specializing in patented modular furniture systems, in successfully completing a multi-million dollar private placement of preferred stock and warrants to various funds and private investors.
Represented Myomo Inc. in its historic initial public offering, raising an aggregate of approximately $8 million in the IPO and a contemporaneous private offering of investment units. Myomo became the first company to list its stock on a national securities exchange upon completion of an IPO under SEC Regulation A+ under the Jumpstart Our Business Startups (JOBS) Act of 2012.
Assisted Surna Inc. in completing a $2,685,000 private placement of investment units, each unit consisting of one share of common stock and a warrant to purchase one share of common stock.
Representing a Massachusetts based cannabis grower/management company in a $6 million private securities offering.
Assisted Zeta Acquisition Corp. II in its merger and change of control transaction with Aerpio Therapeutics.
Represented Double Down Asset Management, LLC in its $1.8 million investment in Step Ahead Innovations, LLC, doing business as MindStream, consisting of common and preferred stock.
Represented public issuer Minn Shares, Inc. in its change of control transaction with Titan CNG LLC.
Represented GreenKissNY, Inc. in its $3 million initial public offering under SEC Regulation A+.
Represented GreenKissNY Inc. in connection with its $2 million private placement of equity securities.
Represented Phoenix Color Corp. in sale of company to Visant Corp. for $219 million.
Represented VirnetX Inc. in its going public transaction. It later settled a patent claim with Microsoft for more than $200 million.
Represented MetSchools and affiliates in the sale of the Claremont School in Manhattan to Meritas LLC.
Represented Protea Biosciences Inc. in its going public transaction in 2011 and multiple additional financings through 2014 totaling approximately $20 million.
Represented Eastern Air Lines Group Inc. in $2.5 million private placement.
Represented shell in reverse merger of Intra-Cellular Therapies, Inc., now with a $1 billion market cap.
Represented DFA Intercultural Worldwide LLC in its sale to Dwellworks LLC.
Represented Vertical Lend Inc. in its sale to Upright Holdings Inc.
Represented Sunrise Securities Corp. as underwriter for public offering of $12 million by Liqtech International Inc.
Represented MetSchools, Inc in the offering of up to $6 million in notes.
Represented investment bank in going public transaction of pharmaceutical company and related financing of approximately $5 million.
Represented Livewire Mobile, Inc. in its acquisition of FoneStarz Medial Group Limited.
Represented DanDrit Biotechnology Corp. in its going public transaction and $6 million public offering thereafter.
Represented Leviathan Minerals Group, Inc. in its going public transaction and related $5 million offering of securities through Northland Securities Inc. as placement agent.
Represented Splinternet Holdings, Inc. (now Defentect Group Inc.) in going public through “self-filing” process.
Represented investment bank in $5 million private offering for international mining company.
Represented Lane Capital Markets LLC in $3 million offering by A&P OptMed Partners I, LLC to invest in OptMed Inc.
Represented Biocontrol Ltd. in going public transaction with AmpliPhi Biosciences (formerly Targeted Genetics), a public operating company.
Represented JDF Capital LLC in approximately 12 investments in convertible notes issued by public companies in amounts up to $500,000 each.
Represented supermodel Carol Alt in endorsement deal for nutritional supplement with an equity ownership in the business.
Represented shell in going public transaction of Cougar Biotechnology, later sold for approximately $1 billion.
Represented public vehicle in going public transaction of Puma Biotechnology.
Represented public vehicle in going public transaction of Emmaus Medical Inc.
Created, took public and handled periodic SEC filings on behalf of approximately 200 Form 10 public vehicle companies between 2005 and 2015.
Represented a nuclear waste disposal company in the sale of a business unit to a nuclear services provider.

Selected Speaking Engagements

Panelist, “Cannabis: Navigating Ambiguity as a Transfer Agent,” Securities Transfer Association Annual Conference, Naples, Florida, October 23, 2019
Presenter, “Cannabis 205: What Big Global Companies Should Know About Entering the Cannabis Space,” Duane Morris Cannabis Webinar Series, October 15, 2019
Panelist, “Cannabis & Compliance: How Compliance Officers, Clients and Legal Professionals Navigate a Complicated Legal Environment,” New York City Bar CLE, New York City, September 19, 2019
Panelist, “An Overview of the Legal Marijuana Industry in the U.S.,” 5th Annual Cannabis Private Investment Summit, Duane Morris LLP, September 17, 2019
Presenter, “Mastering Cannabis & Marijuana Regulation CLE,” Telephonic Seminar, Rossdale CLE, July 31, 2019
Interviewed, “The 420 Bedlam Episode,” Let’s Talk Hemp Podcast, June 27, 2019
Interviewed, Thinking Outside the BudPodcast, June 21, 2019
Speaker, “Unpacking Access to North American Capital Markets,” INCBA Cannabis Law Sessions at MJBizConNEXT, June 11, 2019
Speaker, “Legal and Financial Regulations on the Cannabis Industry,” Lawline Webinar, April 5, 2019
Speaker, “Cannabanoid of Everything,” American Israel Cannabis Association, New York City, March 26, 2019
Speaker, “Morning Keynote,” Capital Roundtable: Cannabis, New York City, March 7, 2019
Moderator, “Ethics in Cannabis Reporting,” Cannabis Media Summit, New York, NY, December 7, 2018
Panelist, “Budding Industries- A Cannabis Entrepreneurship Panel”, Entrepreneur’s Organization (EO), Brooklyn, NY, October 25, 2018
Panelist, “Advanced Cannabis Investment Workshop – Beyond the Basics,” Cannabis World Congress and Business Expo, workshop led by New Frontier Data, Boston, MA, October 17, 2018
Interviewed on “Cannabrunch 2018,” CFN Media Group, October 3, 2018
Panelist, “Financing Issues Facing Late-Stage Private Companies and Smaller Reporting Companies,” Practising Law Institute’s 50th Annual Institute on Securities Regulation, New York City, November 7, 2018
Served as a “shark” in questioning three emerging cannabis companies at the ArcView International Investor Forum in Chicago, IL on September 18, 2018.
Led a roundtable discussion on East Coast Cannabis at the ArcView International Investor Forum in Chicago, IL on September 18, 2018.
Speaker, “An Overview of the Legal Marijuana Industry in the U.S.,” 4th Annual Cannabis Private Investment Summit, New York, New York, September 13, 2018
Panelist, “Public and Private: Preparing for an IPO or Merger,” National Cannabis Bar Association, Cannabis Business Summit and Expo, Washington, DC., September 8, 2018
Interviewed on “REG A+ – Is It the Best Kept Secret for Access to Capital?” Karen Rands’ Compassionate Capitalist, August 13, 2018
Panelist, “Investing in the Cannabis Industry,” Family Office & Private Wealth Management Forum, Gurney’s Newport Resort & Marina, Newport, Rhode Island, July 17, 2018
Panelist, “Securities Law Issues in Cryptocurrency,” Blockchain World Conference, Harrah’s Resort, Atlantic City, New Jersey, July 13, 2018
Faculty, “Clearing the Haze – Banking and Financing in the Cannabis Industry,” Clear Law Institute, Webinar, June 25, 2018
Presenter, “Cannabis 106: Banking and Financing in the Cannabis Industry,” (video replay) Duane Morris Cannabis Webinar Series, June 19, 2018
Moderator, “Down in the Trenches: What it’s Like to Steer a Company Through an Offering,” The Reg A Conference, TKP New York Conference Center, New York, New York, June 12, 2018
Panelist, “Don’t Mess with Sessions: Making Sure Your Business Is Legally Compliant,” Cannabis World Congress & Business Exposition, Jacob K. Javits Convention Center, New York, New York, June 1, 2018
Speaker, “The Future of East Coast Cannabis,” Duane Morris LLP, New York, New York, May 29, 2018
Panelist, “How to Invest in Cannabis Without Getting Burned,” HighNY, New York, New York, April 12, 2018
Speaker, “Regulation A+ at a Glance,” National Investment Banking Association, New York, New York, March 26, 2018
Speaker, “Getting Into the Weeds of Legal Marijuana/Cannabis,” NJICLE, New Brunswick, New Jersey, March 26, 2018
Featured on, “Racial Justice Drives Fight for, and Against, Legal Pot in New Jersey,” WNYC News, March 12, 2018
Featured on, “Marijuana Advocates Push for Legalization in New Jersey, Despite Federal Rules,” WNYC News, February 21, 2018
Interviewed in “David Feldman Interview on Reg A +,” LilaMax Video (via YouTube), February 19, 2018
Moderator, “Other Paths to Going Public,” SPAC Conference, New York City, February 15, 2018
Speaker, Deals & Divas 2nd Annual Women in Cannabis Event, New York City, February 5, 2018
Speaker, Women Grow Leadership Summit 2018, Denver, February 1-2, 2018
Panelist, “The Business of Cannabis,” The Long Island Business News, Melville, New York, November 9, 2017
Panelist, “Market-Driven Financing, Capital Solutions to Accelerate Growth,” CohnReznick’s Liquidity and Capital Raising National Forum, New York, October 17, 2017
Featured on “MassRoots, Inc. – A Leading Technology Platform for the Regulated Cannabis Industry @The OTC Markets,” Small Cap Nation Video, September 28, 2017
Moderator, “What Could the NAFTA Renegotiations Mean for Your Business?” Duane Morris LLP, New York, August 15, 2017
Featured on “David Feldman, Esq., Brings Insight into the Reg A+/Crowdfunding Opportunity,” Small Cap Nation, July 20, 2017
Speaker, “The SEC Reopens the Front Door – Update on Regulation A+ IPOs,” Lawline CLE Webinar, September 15, 2017
Speaker, “Holy Smokes, Cannabis is Big Business,” Alliance of M&A Advisors Summer Conference, July 20, 2017
Presenter, “Financing The Business,” Clearing the Smoke: Legal Pathways to Success in the Cannabis Industry, Philadelphia, June 19, 2017
Speaker, “Cannabis – Investing in One of the Fastest ‘Growing’ Life Sciences Segments,” ACG Webinar, May 9, 2017
Panelist, “Small Business Capital Formation after the JOBS Act: Where Do We Stand?,” ABA CLE Webinar, April 24, 2017
Speaker, “Banking and Financing in the Cannabis Industry,” Lawline Webinar, April 21, 2017
Speaker, “Regulation A+ and Other Financing Opportunities,” Alzheimer’s Association Business Consortium (AABC), April 4, 2017
Speaker, “Regulation A+: After the Offering,” Security Traders Association of New York Annual Capital Markets Conference, New York, March 30 2017
Panelist, “Regulation A+: Bringing Back the Smallcap IPO,” National Investment Banking Association’s New York Investment Conference, February 28, 2017
Moderator, “Bringing Back the Small Cap IPO – Reg A 2017,” Webcast from the floor of the New York Stock Exchange, January 19, 2017
Moderator, “State of the Cannabis Industry,” Deals & Divas, New York, January 17, 2017
Panelist, “Cannabis – Investing in One of the Fastest Growing Segments of the Life Sciences Industry,” Association for Corporate Growth Westchester/Hudson chapter, Tarrytown, NY, December 9, 2016
Panelist, “How Capital Formation Options Are Working for Small Businesses After the Implementation of the JOBS Act (David’s presentation on Regulation A+ starts at approximately minute 34 on the webcast),” Securities and Exchange Commission’s Government-Business Forum, November 17, 2016
Panelist, “Regulation A+: The New ‘Mini IPO,'” DealFlow Media Crowdfunding Conference, New York, October 2016
Speaker, “Crowdfunding 101,” New York City Bar Justice Center – Neighborhood Entrepreneur Law Project, Queens, NY, September 2016
Speaker, “Legal Issues for Entrepreneurs,” Venture for America bootcamp training for incoming Fellows, Providence, RI, July 2016
Moderator, “Understanding Regulation A+ and the ‘Mini-IPO’,” 2016 Marcum Microcap Conference, June 2, 2016.
Speaker, “Legal Issues for Cannabis Companies,” Women Grow NYC Signature Networking Event, New York City, March 3, 2016
Speaker, “Investing in the Emerging Cannabis Industry While Managing Risk,” New York City Cannabis Investor Symposium, New York, January 13, 2016
Host of Webinar, “Legal Issues in Starting a Business,” Venture for America, January 12, 2016

Selected Publications

Author Credits

Contributor, Monthly Column on Cannabis Law for Honeysuckle Magazine
Contributor, Green Entrepreneur
Author, David Feldman Blog
Author, “The Uncut Entrepreneur,” Monthly Column in SmartCEO Magazine
Author, “Why the Trend of Going Public in Canada May be Ending,” Green Entrepreneur, May 31, 2019
Author, “Blunt Legal Talk: Why Social Justice Matters in the Cannabis Debate,” Honey Suckle, March 18, 2019
Author, “Who Will be the Winners and Losers When Federal Cannabis Prohibition Ends?” The Green Entrepreneur, January 25, 2019
Author, “Regulation A+ and Other Alternatives to a Traditional IPO: Financing Your Growth Business Following the JOBS Act,”Bloomberg Press, February 2018
Co-author, “SEC Reopens Front Door for Small Cap Listings as First Regulation A+ IPO Trades on National Exchange,” Duane Morris Alert, June 15, 2017
Author, “Is Cannabis the New Alternative Investment?” The Daily Marijuana Observer,June 2, 2017
Chapter Author, Crowdfunding, John Wiley & Sons, 2014
Author, The Entrepreneur’s Growth Startup Handbook, John Wiley & Sons, 2013
Author, Reverse Mergers and Other Alternatives to a Traditional IPO, Bloomberg Press, first edition, 2006, second edition, 2009
Chapter Author, The Issuer’s Guide to PIPEs, Bloomberg Press, 2009
Chapter Author, PIPES: Revised and Updated Edition, Bloomberg Press, 2005

Quoted and Profiled

Quoted, “Cannabis M&A Flares As Players Bet On US Legalization,” Law 360, October 17, 2019
Quoted, “The New York State Lawmaker Who’s Leading the Push to Legalize Marijuana Just Leveled a Stark Warning Against Vape Makers,” Business Insider,September 19, 2019
Quoted, “How SPACs Get Around Wall Street’s Pot Aversion,” The Deal Pipeline, June 26, 2019
Quoted, “Traditional Exchanges Pull Back From Reg A+ IPOs Due to Fraud Concerns,” Yahoo Finance, June 12, 2019
Quoted, “Exchanges Shy Away From Mini-IPOs After Fraud Concerns,” The Wall Street Journal, June 10, 2019
Quoted, “Investing in Cannabis: International Investments, Public Perception, Valuation and Service Providers,” Hedge Fund Law Report, June 6, 2019
Interviewed by PotNetwork News, “Duane Morris Attorney David Feldman on What to Expect at the FDA Hearings on CBD This Week,” May 31, 2019
Quoted, “Investing in Cannabis: Implications of Federal Illegality and Residency Requirements,” Hedge Fund Law Report, May 30, 2019
Quoted, “An Analysis of YOLO ETF Holdings Shows Diverse Portfolio,” ETF Trends, May 24, 2019
Quoted, “PE-Backed Lovesac’s Offering Potentially Worth Nearly $100M,” Law360, May 20, 2019
Quoted, “Investing in Cannabis: Structuring Investments, Due Diligence, Offering Documents and the BSA,” Hedge Fund Law Report, May 16, 2019
Quoted, “SEC ‘Not Anxious’ To Approve Reg A+ Token Offerings,” Law360, May 9, 2019
Quoted, “Will FDA Draw a Line Between Other CBD Products and Pharmaceuticals?” CBD Intel, April 29, 2019
Quoted, “When Will CBD Foods Be Legal in the US? Don’t Hold Your Breath,” CBD Intel, April 25, 2019
Quoted, “Greenlane IPO Could Lift Prospects Of Cannabis-Related Cos.,” Law360, April 24, 2019
Quoted, “Top Cannabis CEOs Say Canopy Growth’s $3.4 Billion Purchase of Pot Cultivator Acreage ‘Shakes the Foundation of What’s Been True’ and Will Spur a Cannabis M&A Boom,” Business Insider, April 22, 2019
Quoted, “Canopy Growth Strikes Deal to Have Right to Buy Acreage Holdings,” Digital Journal, April 18, 2019
Quoted, “Canadian Weed Giant Canopy Growth Strikes $3.4 Billion Deal to Buy Acreage After Federal Legalization,” CNBC, April 18, 2019
Quoted, “With Gottlieb Leaving FDA, Uncertainty Over CBD and Hemp Regulation Remains,” Corporate Counsel, March 6, 2019
Quoted, “Don’t Call It ‘Weed,’ and Other Tips from the Cannabis Media Summit,” The New Yorker, January 21, 2019
Featured, “Duane Morris Cannabis Group Adds Team Leads In NY, SF,” Law360, January 18, 2019
Featured, “Meet the Duane Morris Lawyers Who Are Working on Some of the Biggest Deals in the Booming Marijuana Industry,” Business Insider, January 9, 2019
Quoted, “Public Companies Can Claim ‘Mini-IPO’ to Raise up to $50 Million,” Congressional Quarterly, December 20, 2018
Quoted, “Cannabis PIPEs Market Prepares for New Highs,” The Deal, October 17, 2018
Quoted, “SEC Warning Unlikely to Slow Green Wave,” The Deal, September 11, 2018
Quoted, “SEC Charges Cannabis Investment Fund Founder With Fraud,” The Dealflow Newsletter, September 2018
Quoted, “Should Cannabis Investors be Worried After the SEC’s Warning?” The Street, September 6, 2018
Quoted, “Canopy Growth Leads Cannabis Debt Bonanza” The Street, July 9, 2018
Quoted, “Cannabis PIPEs: Smoking Hot, Eh?” The Deal, June 27, 2018
Quoted, “Dodd-Frank Rollback Also Expands Reg A+ Benefits,” Law360, May 30, 2018
Quoted, “Cannabis Industry Seeks to Woo Banks Despite Federal Roadblocks,” The Street, May 23, 2018
Quoted, “How to Avoid Weed-Investing Scams,” The Street, May 7, 2018
Quoted, “4/20 Marks a Big Year for Cannabis PIPEs,” The Deal, April 20, 2018
Quoted, “Canadian Cannabis Investor Continues California Green Rush,” The Deal Pipeline, March 29, 2018
Quoted, “Jamaican Cannabis in Focus After Scythian Invests In Marigold,” The Deal, March 23, 2018
Quoted, “While Some Will Get Lucky, the Big Winners In Cannabis Will Take These 4 Pieces of Advice From the Experts,” , March 5, 2018
Quoted, “Can Reg A+ Companies Get a Taste of Hostess SPAC’s Sweet Success?” RegAResearch, March 1, 2018
Quoted, “Reg A+ ‘Mini-IPOs’ Face Market Resistance,” Law360, February 23, 2018
Quoted, “Canadian Liquor Stores Chain Hits the PIPEs,” The Street, February 5, 2018
Featured, “‘Godfather’ of Reg A+ Says Regulators Should Raise IPO Ceiling to $100 Million,” RegAResearch, January 24, 2018
Author, “Reg A+: The SEC Reopens the Front Door to Bring Back the Smallcap IPO,” The STA Newsletter 2018, January 2018
Quoted, “My Legal Eagle,” The ABC’s of CBD
Quoted, “Cannabust?,” Long Island Business News, December 1, 2017
Quoted, “Canadian Cannabis Companies Hit the PIPE Market,” The Deal, November 3, 2017
Quoted, “For Cannabis Companies, Success Means Tackling Legal Complexity,” Co, November 1, 2017
Interviewed in PubCoCEo,”Interview With David Feldman, Author of ‘Regulation A+ and Other Alternatives to a Traditional IPO’,” October 30, 2017
Quoted in, net, “Where Have the Public Companies Gone – and Why?”, June 16, 2017
Quoted in, Growth Capitalist, “Late PIPE Deal Backstops Myomo’s Path to First Reg A Exchange Listing,” June 12, 2017
Quoted in Law360, “‘Mini-IPO’ Could Spur More Listings Through Reg A+ Route,” June 12, 2017
Quoted in The Wall Street Journal, “Here’s How To Go Public Without Wall Street,” June 1, 2017: Mentioned in, “Term Sheet – Monday, June 5,” Fortune, June 5, 2017
Quoted in Cannabis Law Report, “Duane Morris Tackling the New Global Cannabis Industry,” May 17, 2017
Profiled in Daily Marijuana Observer, “Better Know a Cannabis-Focused Corporate Lawyer,” May 16, 2017
Quoted in The Deal, “First Reg-Lite Listing Seen Opening the Gates,” March 16, 2017
Quoted in Growth Capitalist, “AltaVista’s Clients Speak Out (Part 3 of 3),” March 10, 2017
Quoted in Business News Daily, “Smart Business Opportunities in the Emerging Legal Cannabis Industry,” February 3, 2017
Quoted in com, “How Reg A+ Could Bring Back the Small-Cap IPO,” January 20, 2017
Quoted in Growth Capitalist, “SEC Forum Takes Stock of Reg A+ Market Progress,” November 23, 2016
Quoted in PIPEs Report, “New Administration Signals Good Times for IPOs,” November 15, 2016
Quoted in Growth Capitalist, “Med-X’s Reg A Offering Suspended by SEC for Late Filing,” September 29, 2016
Quoted in Growth Capitalist, “BeautyKind Gives it Another Go,” regarding recent Regulation A transactions, September 15, 2016
Quoted in Growth Capitalist“SEC Wins States’ Court Challenge of Regulation A Rules,” June 15, 2016
Quoted in MG Magazine“SEC: Help or Hindrance?” April 2016
Quoted in The PIPEs Report “Reg A+ offerings picking up speed,” February 9, 2016
Quoted in Growth Capitalist“State Regulators’ Lawsuit Challenging Reg A+ Goes to Court,” April 19, 2016